Select a Region North America

CASE STUDY | ​MEDICAL INFORMATION CLINICAL TRIAL SUPPORT ​

CASE STUDY | MEDICAL INFORMATION CLINICAL TRIAL SUPPORT ​

Client Success Story

the situation

The Situation

  • In late 2018, EVERSANA was approached by a client to develop a Contact Center program to support the launch of a screening and referral service for the client’s natural history trials for rare or ultra-rare inherited neurological disorders. These diseases include Charcot-Marie-Tooth Disease (CMT4J), Batten Disease (CLN5, CLN7), and Aspartylglucosaminuria (AGU).   The Contact Center program included development of a medical communications management plan, workflow processes, configuration of the EVERSANA medical information system, staff training, and alignment of communication between the client and EVERSANA and was successfully established in 3 months. The program has two components; detailed screening and verification of eligible patients, and subsequent referral to trial sites. Contact center pharmacists have also been trained to answer general questions from patients, family members, or consumers regarding the disease symptoms, genetics, and research.
the solution

The Solution

  • The client asked EVERSANA for “high-touch” medical information services to support the complex screening and referral process for these clinical trials. The client also asked for staff highly trained and knowledgeable in the product’s therapeutic area in the emerging field of gene therapy for rare neurological diseases. A mutual decision was made to use the shared pharmacist staffing model for support of this project. The shared model offers the most cost-efficient process, where the staff is highly trained to meet the client’s needs while at the same time supporting other clients.
  • Specifically, EVERSANA pharmacists were trained to assess if the potential trial subjects had a target disease that was verified by genetic diagnosis. If this was not verified, the pharmacist directed the subject to follow up with his or her physician. Once a genetic diagnosis was ascertained, the EVERSANA pharmacist could forward the patient’s information to the study site for further eligibility screening. Another challenge of this project was that subjects could be contacting EVERSANA from outside the United States. Accordingly, interpretation and translation services were made available for inquiries from non-English speaking customers.
the results

The Results

  • The client continued to work with EVERSANA as more clinical trial sites opened and as additional studies were conducted. 
  • The client also has expressed their appreciation for our forward-thinking and flexibility in services and operations to meet their tailored, ever-changing needs.

The client has expressed their appreciation for our forward-thinking and flexibility in services and operations to meet their tailored, ever-changing needs.

문의

Results Matter.

Ask us how we can help you improve your Medical Information services.